
Insider and congress filings
Medtronic Plc (MDT)
NYSE · Healthcare · 356 insider transactions · 177 congress trades · last filed 7 days agoS&P 500
About Medtronic Plc
from the company's filings and listing, as of Oct 27, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Geoffrey Straub Martha
- Employees
- 95,000
- Listed since
- -
- Market value
- $121.3B
- Price to earnings (12 mo)
- 23.2
- Net income per share, as reported (12 mo)
- $4.09
- Dividend yield
- 3.02%
GetSignal News
1 article · newest first| Headline | Source | Date |
|---|---|---|
| Medtronic presents registry results for Sphere-9 and PulseSelect at APHRS 2026The global analyses cover patients with atrial fibrillation and ventricular tachycardia, and Medtronic said the results were positive. | Company release | Oct 22, 2026 |
Written by GetSignal with AI from SEC filings and the company's own press releases; each article links to its source. Not investment advice. Company news from every company we cover
Earnings
6 reported quarters · next on Nov 17, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q1 FY2027reported Sep 1, 2026 | $1.45 | $1.39 | $9.8B | $9.5B | EPS beatRevenue beat |
| Q4 FY2026reported Jun 3, 2026 | $1.55 | $1.54 | $9.8B | $9.6B | EPS in lineRevenue beat |
| Q3 FY2026reported Feb 17, 2026 | $1.36 | $1.34 | $9.0B | $8.9B | EPS in lineRevenue in line |
| Q2 FY2026reported Nov 18, 2025 | $1.36 | $1.31 | $9.0B | $8.9B | EPS beatRevenue in line |
| Q1 FY2026reported Aug 19, 2025 | $1.26 | $1.23 | $8.6B | $8.4B | EPS beatRevenue beat |
| Q4 FY2025reported May 21, 2025 | $1.62 | $1.58 | $8.9B | $8.8B | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2026 · proxy filed Aug 17, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Geoff MarthaChairman and Chief Executive Officer | $1.4M | $13.7M | $7.9M | $22.9M |
| Thierry PiétonEVP, Chief Financial Officer | $850K | $3.2M | $4.6M | $8.6M |
| Mike MarinaroEVP & President Medical Surgical Portfolio & Americas | $820K | $3.6M | $2.4M | $6.8M |
| Michelle QuinnEVP, General Counsel and Secretary | $600K | $3.5M | $2.6M | $6.7M |
The summary compensation table from the proxy statement for fiscal 2026, with titles as filed then. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $8.9B | 114,020,787 | +0.7% | 8.91% |
| Vanguard Capital Management LLC | $6.6B | 83,816,735 | +0.6% | 6.55% |
| State Street Corp | $5.0B | 63,399,315 | +2.7% | 4.95% |
| Vanguard Portfolio Management LLC | $2.7B | 34,059,967 | +1.8% | 2.66% |
| Massachusetts Financial Services Co | $2.6B | 19,872,600 | -7.3% | 1.55% |
| Geode Capital Management, LLC | $2.4B | 30,192,015 | +5.1% | 2.36% |
| JPMorgan Chase & Co. | $2.2B | 27,784,471 | -45.5% | 2.17% |
| Bank of America Corp | $1.7B | 21,322,401 | -18.0% | 1.67% |
| Morgan Stanley | $1.5B | 19,444,871 | -6.1% | 1.52% |
| Deutsche Bank AG | $1.4B | 18,449,877 | -2.9% | 1.44% |
| Invesco Ltd. | $1.4B | 17,885,150 | +6.5% | 1.40% |
| Franklin Templeton Inc | $1.4B | 17,550,983 | +23.8% | 1.37% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
Tracked fund managers holding MDT
2 managers| Manager | Value | Shares | Share of book |
|---|---|---|---|
| Renaissance TechnologiesJim Simons | $247.8M | 3,167,741 | 0.3% |
| Trexquant Investment | $88.6M | 1,132,741 | 0.5% |
2 of the 97 fund managers we track list MDT shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.
Open-market insider trades
5 filings shown · newest filing first| Insider | Action | Shares | Price | Value | Trade date | Delay (business days) |
|---|---|---|---|---|---|---|
| Geoffrey MarthaChairman and CEO | Sold · scheduled | 50,000 | $95.00 | $4.8M | Oct 15, 2026filed Oct 16, 2026 | 1d |
| Michael MarinaroEVP, Pres Medsurg and Americas | Sold · scheduled | 10,420 | $96.00 | $1.0M | Oct 15, 2026filed Oct 16, 2026 | 1d |
| Harry Skip KiilEVP & President Cardiovascular | Sold | 1,483 | $93.65 | $139K | Sep 16, 2026filed Sep 17, 2026 | 1d |
| Matthew R. WalterSVP, Chief HR Officer | Sold · scheduled | 3,102 | $83.15 | $258K | Jul 8, 2026filed Jul 9, 2026 | 1d |
| Harry Skip KiilEVP & President Cardiovascular | Sold · 2 lines | 4,189 | $80.44 | $337K | Jun 8, 2026filed Jun 9, 2026 | 1d |
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Other Form 4 activity (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Kevin E. LoftonDirector | Other (see filing) | 182 | Oct 15, 2026 |
| Denise L. BlomquistChief Accounting Officer | Gift | 600 | Sep 15, 2026 |
| Michael MarinaroEVP, Pres Medsurg and Americas | Tax withholding | 1,084 | Aug 20, 2026 |
| Matthew R. WalterSVP, Chief HR Officer | Stock award | 61,163 | Aug 3, 2026 |
| Matthew R. WalterSVP, Chief HR Officer | Tax withholding | 1,675 | Jul 31, 2026 |
| Denise L. BlomquistChief Accounting Officer | Stock award | 3,703 | Aug 3, 2026 |
| Denise L. BlomquistChief Accounting Officer | Tax withholding | 212 | Jul 31, 2026 |
| Geoffrey MarthaChairman and CEO | Stock award | 713,516 | Aug 3, 2026 |
| Geoffrey MarthaChairman and CEO | Tax withholding | 15,810 | Jul 31, 2026 |
| Harry Skip KiilEVP & President Cardiovascular | Stock award | 97,860 | Aug 3, 2026 |
| Harry Skip KiilEVP & President Cardiovascular | Tax withholding | 3,074 | Jul 31, 2026 |
| Michael MarinaroEVP, Pres Medsurg and Americas | Stock award | 162,355 | Aug 3, 2026 |
| Michael MarinaroEVP, Pres Medsurg and Americas | Tax withholding | 3,356 | Jul 31, 2026 |
| Thierry PietonEVP & Chief Financial Officer | Stock award | 122,324 | Aug 3, 2026 |
| Michelle QuinnEVP, GC and Secretary | Stock award | 67,279 | Aug 3, 2026 |
| Kweli ThompsonEVP & President, Neuroscience | Stock award | 73,396 | Aug 3, 2026 |
| Kweli ThompsonEVP & President, Neuroscience | Tax withholding | 1,739 | Jul 31, 2026 |
| Michelle QuinnEVP, GC and Secretary | Tax withholding | 2,069 | Jul 28, 2026 |
| Kweli ThompsonEVP & President, Neuroscience | Other Form 4 entry (see filing) | 22,363 | Jul 28, 2026 |
| Kweli ThompsonEVP & President, Neuroscience | Other Form 4 entry (see filing) | 1,540 | Jul 29, 2025 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Congress trades in MDT
20 disclosures of 177 on record · median 25d of the 45 allowedSince the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Kevin HernJoint | Stock | Sale | $15,001 - $50,000 | +2.0% since the saleEstimated exit price $92.90, close on Mon Aug 24Current price $94.79, close on Mon Oct 26 | Aug 24, 2026 | Sep 1, 2026 | 8d |
| Richard McCormick | Stock | Sale | $1,001 - $15,000 | +10.6% since the saleEstimated exit price $85.71, close on Thu Jul 30Current price $94.79, close on Mon Oct 26 | Jul 30, 2026 | Aug 14, 2026 | 15d |
| Julie JohnsonJointFiled late | Stock | Sale | $1,001 - $15,000 | +14.0% since the saleEstimated exit price $83.16, close on Wed May 7, 2025Current price $94.79, close on Mon Oct 26 | May 7, 2025 | Aug 5, 2026 | 455d |
| Alan ArmstrongSelf | Stock | Purchase | $1,001 - $15,000 | +8.8% since the tradeEstimated entry price $87.14, close on Fri Mar 27Current price $94.79, close on Mon Oct 26 | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +24.5% since the tradeEstimated entry price $76.15, close on Fri May 15Current price $94.79, close on Mon Oct 26 | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +24.8% since the tradeEstimated entry price $75.98, close on Wed May 27Current price $94.79, close on Mon Oct 26 | May 27, 2026 | Jun 9, 2026 | 13d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +24.5% since the saleEstimated exit price $76.15, close on Fri May 15Current price $94.79, close on Mon Oct 26 | May 15, 2026 | Jun 8, 2026 | 24d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | +5.5% since the saleEstimated exit price $89.89, close on Tue Mar 10Current price $94.79, close on Mon Oct 26 | Mar 10, 2026 | Apr 7, 2026 | 28d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +8.7% since the saleEstimated exit price $87.17, close on Mon Mar 23Current price $94.79, close on Mon Oct 26 | Mar 23, 2026 | Apr 7, 2026 | 15d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +10.6% since the saleEstimated exit price $85.74, close on Mon Mar 30Current price $94.79, close on Mon Oct 26 | Mar 30, 2026 | Apr 7, 2026 | 8d |
| Kevin HernJoint | Stock | Sale | $15,001 - $50,000 | +10.0% since the saleEstimated exit price $86.16, close on Fri Mar 20Current price $94.79, close on Mon Oct 26 | Mar 20, 2026 | Apr 3, 2026 | 14d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -6.0% since the tradeEstimated entry price $100.88, close on Fri Jan 23Current price $94.79, close on Mon Oct 26 | Jan 23, 2026 | Feb 6, 2026 | 14d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -6.5% since the saleEstimated exit price $101.34, close on Thu Jan 22Current price $94.79, close on Mon Oct 26 | Jan 22, 2026 | Feb 6, 2026 | 15d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | -3.7% since the saleEstimated exit price $98.48, close on Thu Dec 18, 2025Current price $94.79, close on Mon Oct 26 | Dec 18, 2025 | Jan 15, 2026 | 28d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | -1.4% since the saleEstimated exit price $96.14, close on Thu Nov 13, 2025Current price $94.79, close on Mon Oct 26 | Nov 13, 2025 | Dec 11, 2025 | 28d |
| Richard McCormick | Stock | Purchase | $1,001 - $15,000 | +4.9% since the tradeEstimated entry price $90.40, close on Wed Nov 5, 2025Current price $94.79, close on Mon Oct 26 | Nov 5, 2025 | Dec 9, 2025 | 34d |
| Richard McCormick | Stock | Purchase | $1,001 - $15,000 | n/a | Mar 15, 2023 | Sep 17, 2025 | 917d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | +3.1% since the saleEstimated exit price $91.98, close on Thu Aug 14, 2025Current price $94.79, close on Mon Oct 26 | Aug 14, 2025 | Sep 11, 2025 | 28d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +5.7% since the tradeEstimated entry price $89.64, close on Mon Aug 4, 2025Current price $94.79, close on Mon Oct 26 | Aug 4, 2025 | Sep 9, 2025 | 36d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +10.2% since the saleEstimated exit price $86.02, close on Fri Jun 27, 2025Current price $94.79, close on Mon Oct 26 | Jun 27, 2025 | Jul 9, 2025 | 12d |
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Every Congress trade in MDT, filterable by party, chamber, type and account.
Members of Congress reporting a position
15 members · estimate, as of Oct 26, 202615 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Gary C. Peters | Democrat · Senate | $15,001 - $50,000 | 1.0% |
| Debbie Dingell | Democrat · House | $15,001 - $50,000 | 0.4% |
| Robert Bresnahan | Republican · House | $15,001 - $50,000 | 0.2% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $15,001 - $50,000 | 0.1% |
| Daniel Meuser | Republican · House | $15,001 - $50,000 | 0.7% |
| Harriet M. Hageman | Republican · House | $15,001 - $50,000 | 0.5% |
| George Whitesides | Democrat · House | $1,001 - $15,000 | 0.1% |
| Ron Wyden | Democrat · Senate | $1,001 - $15,000 | 0.1% |
| Shelley Moore Capito | Republican · Senate | $1,001 - $15,000 | 0.4% |
| Cliff Bentz | Republican · House | $1,001 - $15,000 | 0.5% |
| James Comer | Republican · House | $1,001 - $15,000 | 1.4% |
| Lucy McBath | Democrat · House | $1,001 - $15,000 | 0.1% |
| Robert B. Aderholt | Republican · House | $1,001 - $15,000 | 1.0% |
| Robert Onder | Republican · House | $1,001 - $15,000 | 0.2% |
| Richard McCormick | Republican · House | $1,001 - $15,000 | 2.2% |
Estimate, as of Oct 26, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Are insiders buying or selling MDT?
Across the 5 most recent open-market filings shown here, 0 were purchases and 5 were sales. 3 were scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress have traded MDT?
Kevin Hern, Richard McCormick, Julie Johnson, Alan Armstrong, Ro Khanna and Gilbert Ray Cisneros, Jr. disclosed MDT transactions in the filings shown here.
Which members of Congress hold MDT?
15 members of Congress report a position in MDT in the estimate we hold as of Oct 26, 2026. The largest estimated positions, in the $15,001 - $50,000 band, include Gary C. Peters, Debbie Dingell and Robert Bresnahan. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is MDT in the S&P 500 or the Nasdaq 100?
Medtronic Plc is a current member of the S&P 500, per the membership list we hold as of Oct 28, 2026. Current members of either index get a page here whatever their filing history.
How quickly are MDT trades disclosed?
Insider filings on this page reached the public a median of 1 business day after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 25 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 28, 2026.
